Effect of doxapram on the electrical activity of the diaphragm waveform pattern of preterm infants

Pediatr Pulmonol. 2022 Jun;57(6):1483-1488. doi: 10.1002/ppul.25889. Epub 2022 Mar 23.

Abstract

Objective: This study aimed to evaluate the change in the waveform pattern of the electrical activity of the diaphragm (Edi) following the administration of doxapram in extremely preterm infants ventilated with neurally adjusted ventilatory assist (NAVA).

Study design: We conducted this retrospective cohort study in our neonatal intensive care unit between November 2019 and September 2021. The study participants were extremely preterm infants under the gestational age of 28 weeks who were ventilated with NAVA and administered doxapram. We collected the data of the Edi waveform pattern and calculated the proportion. To analyze the change in the proportion of the Edi waveform pattern, we compared the proportion of the data for 1 h before and after doxapram administration.

Results: Ten extremely preterm infants were included. Almost all the patients' respiratory condition improved after doxapram administration. The ventilatory parameters-Edi peak, Edi minimum, peak inspiratory pressure, time in backup ventilation, and number of switches to backup ventilation-did not change significantly. However, the proportion of phasic pattern significantly increased (before: 46% vs. after: 72%; p < 0.05), whereas the central apnea pattern significantly decreased after doxapram administration (before: 31% vs. after: 8.3%; p < 0.05). The proportion of irregular low-voltage patterns tended to decrease, albeit with no significant changes.

Conclusion: Our results indicated that the proportion of Edi waveform patterns changed following doxapram administration. Edi waveform pattern analysis could be a sensitive indicator of effect with other intervention for respiratory conditions.

Keywords: bronchopulmonary dysplasia; neonatal intensive care units; respiratory system agents.

MeSH terms

  • Diaphragm*
  • Doxapram / pharmacology
  • Humans
  • Infant
  • Infant, Extremely Premature
  • Infant, Newborn
  • Interactive Ventilatory Support*
  • Retrospective Studies

Substances

  • Doxapram